Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Suspended × Cytomegalovirus Infections × Clear all

Phase

Status

Recruiting 3 Completed 3 Withdrawn 1 Unknown 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 11 Neoplasm Metastasis 8 Leukemia, Myeloid, Acute 8 Breast Neoplasms 6 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Myelodysplastic Syndromes 5 Lung Neoplasms 5 Melanoma 4 Glioma 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Lymphoma 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Glioblastoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02988258 2018-09-12

CMV_TCR-001

University College, London

Phase 1 Suspended

Cytomegalovirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡